drugset / Trial / NCT01582880
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the pilot study is to test the efficacy and safety of riboflavin/Ultraviolet A (UVA) cross-linked human donor corneas as carriers for the Boston Keratoprosthesis (Boston KPro) in patients with higher risk for corneal melting (keratolysis).
Timeline
- Start
- 2012-03
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Riboflavin | Other / unclassified | 0.1 % | — |